Elite Pharmaceuticals Inc (ELTP)
0.6168
0.00 (0.00%)
USD |
OTCM |
Nov 22, 16:00
Elite Pharmaceuticals Free Cash Flow: 1.685M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.685M |
| June 30, 2024 | 0.0845M |
| March 31, 2024 | -4.091M |
| December 31, 2023 | -3.315M |
| September 30, 2023 | -1.082M |
| June 30, 2023 | -4.456M |
| March 31, 2023 | -2.398M |
| December 31, 2022 | -3.489M |
| September 30, 2022 | 0.031M |
| June 30, 2022 | 3.647M |
| March 31, 2022 | 6.010M |
| December 31, 2021 | 3.734M |
| September 30, 2021 | 1.968M |
| June 30, 2021 | 3.781M |
| March 31, 2021 | 2.864M |
| December 31, 2020 | 2.560M |
| September 30, 2020 | 1.063M |
| June 30, 2020 | -1.221M |
| March 31, 2020 | -1.829M |
| December 31, 2019 | -2.727M |
| September 30, 2019 | -3.702M |
| June 30, 2019 | -4.738M |
| March 31, 2019 | -6.812M |
| December 31, 2018 | -5.588M |
| September 30, 2018 | -4.693M |
| Date | Value |
|---|---|
| June 30, 2018 | -5.545M |
| March 31, 2018 | -5.084M |
| December 31, 2017 | -8.541M |
| September 30, 2017 | -9.167M |
| June 30, 2017 | -9.367M |
| March 31, 2017 | -8.989M |
| December 31, 2016 | -4.584M |
| September 30, 2016 | -5.304M |
| June 30, 2016 | -6.937M |
| March 31, 2016 | -4.714M |
| December 31, 2015 | -9.205M |
| September 30, 2015 | -10.46M |
| June 30, 2015 | -11.03M |
| March 31, 2015 | -17.10M |
| December 31, 2014 | -14.25M |
| September 30, 2014 | -13.00M |
| June 30, 2014 | -9.266M |
| March 31, 2014 | -4.777M |
| December 31, 2013 | -3.424M |
| September 30, 2013 | -2.052M |
| June 30, 2013 | -1.978M |
| March 31, 2013 | -1.898M |
| December 31, 2012 | -1.422M |
| September 30, 2012 | -1.732M |
| June 30, 2012 | -1.385M |
Free Cash Flow Range, Past 5 Years
-4.456M
Minimum
Jun 2023
6.010M
Maximum
Mar 2022
0.141M
Average
0.0578M
Median
Free Cash Flow Benchmarks
| Biomarin Pharmaceutical Inc | 300.88M |
| BioCardia Inc | -7.309M |
| Zevra Therapeutics Inc | -69.57M |
| Verrica Pharmaceuticals Inc | -59.62M |
| Terns Pharmaceuticals Inc | -74.83M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 1.457M |
| Cash from Investing (Quarterly) | 0.0176M |
| Cash from Financing (Quarterly) | -0.3207M |
| Free Cash Flow Per Share (Quarterly) | 0.0013 |
| Free Cash Flow to Equity (Quarterly) | 1.595M |
| Free Cash Flow to Firm (Quarterly) | 1.653M |
| Free Cash Flow Yield | 0.26% |